Prem Watsa - Fairfax Financial Holdings
Holding/activity history for Pfizer Inc. (PFE)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 460,900 | 1.21 | $28.93 | ||
| 2024 Q2 | 460,900 | 1.09 | $27.98 | ||
| 2024 Q1 | 460,900 | 1.04 | $27.73 | ||
| 2023 Q4 | 460,900 | 0.90 | $28.78 | ||
| 2023 Q3 | 460,900 | 1.00 | $33.17 | ||
| 2023 Q2 | 460,900 | 1.10 | $36.67 | ||
| 2023 Q1 | 460,900 | 1.34 | $40.78 | ||
| 2022 Q4 | 460,900 | 0.64 | $51.25 | ||
| 2022 Q3 | 460,900 | 0.57 | Add 14.97% | 0.07 | $43.84 |
| 2022 Q2 | 400,900 | 0.74 | $52.50 | ||
| 2022 Q1 | 400,900 | 0.69 | $51.77 | ||
| 2021 Q4 | 400,900 | 0.76 | $59.04 | ||
| 2021 Q3 | 400,900 | 0.56 | $43.00 | ||
| 2021 Q2 | 400,900 | 0.51 | $39.16 | ||
| 2021 Q1 | 400,900 | 0.51 | Add 33.23% | 0.13 | $36.23 |
| 2020 Q4 | 300,900 | 0.49 | Buy | 0.49 | $36.81 |
| 2018 Q1 | 0 | 0 | Sell 100.00% | 0.54 | |
| 2017 Q4 | 210,000 | 0.54 | $36.25 | ||
| 2017 Q3 | 210,000 | 0.61 | $35.68 | ||
| 2017 Q2 | 210,000 | 0.62 | $33.59 | ||
| 2017 Q1 | 210,000 | 0.58 | $34.20 | ||
| 2016 Q4 | 210,000 | 0.58 | $32.49 | ||
| 2016 Q3 | 210,000 | 0.64 | $33.86 | ||
| 2016 Q2 | 210,000 | 0.72 | $35.20 | ||
| 2016 Q1 | 210,000 | 0.55 | $29.62 | ||
| 2015 Q4 | 210,000 | 0.55 | Reduce 10.64% | 0.07 | $32.27 |
| 2015 Q3 | 235,000 | 0.68 | $31.40 | ||
| 2015 Q2 | 235,000 | 0.58 | $33.51 | ||
| 2015 Q1 | 235,000 | 0.58 | $34.80 | ||
| 2014 Q4 | 235,000 | 0.47 | $31.15 | ||
| 2014 Q3 | 235,000 | 0.47 | $29.57 | ||
| 2014 Q2 | 235,000 | 0.48 | $29.67 | ||
| 2014 Q1 | 235,000 | 0.53 | $32.12 | ||
| 2013 Q4 | 235,000 | 0.56 | $30.62 | ||
| 2013 Q3 | 235,000 | 0.45 | $28.71 | ||
| 2013 Q2 | 235,000 | 0.28 | $28.05 | ||
| 2013 Q1 | 235,000 | 0.26 | $28.84 | ||
| 2012 Q4 | 235,000 | 0.24 | $25.09 | ||
| 2012 Q3 | 235,000 | 0.31 | $24.84 | ||
| 2012 Q2 | 235,000 | 0.30 | $22.98 | ||
| 2012 Q1 | 235,000 | 0.25 | $22.64 | ||
| 2011 Q4 | 235,000 | 0.29 | $21.64 | ||
| 2011 Q3 | 235,000 | 0.21 | $17.68 | ||
| 2011 Q2 | 235,000 | 0.18 | $20.59 | ||
| 2011 Q1 | 235,000 | 0.17 | $20.31 | ||
| 2010 Q4 | 235,000 | 0.16 | Reduce 6.49% | 0.01 | $17.51 |
| 2010 Q3 | 251,300 | 0.21 | $17.17 | ||
| 2010 Q2 | 251,300 | 0.15 | Add 4.14% | 0.01 | $14.25 |
| 2010 Q1 | 241,300 | 0.13 | $17.15 | ||
| 2009 Q4 | 241,300 | 0.12 | $18.19 | ||
| 2009 Q3 | 241,300 | 0.06 | $16.52 | ||
| 2009 Q2 | 241,300 | 0.07 | Reduce 98.52% | 4.66 | $14.99 |
| 2009 Q1 | 16,314,700 | 5.15 | Reduce 9.02% | 0.51 | $13.62 |
| 2008 Q4 | 17,932,100 | 6.16 | Add 0.55% | 0.03 | $17.71 |
| 2008 Q3 | 17,833,600 | 8.70 | Add 0.03% | 0.00 | $18.34 |
| 2008 Q2 | 17,827,600 | 8.78 | $17.45 |